Global Nafarelin Market Insights, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 115

Report ID: 19899

Nafarelin is a potent agonistic analog of gonadotropin-releasing hormone (GnRH). Nafarelin has been used in the treatments of central precocious puberty and endometriosis.
The global Nafarelin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nafarelin market based on company, product type, end user and key regions.

This report studies the global market size of Nafarelin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nafarelin in these regions.
This research report categorizes the global Nafarelin market by top players/brands, region, type and end user. This report also studies the global Nafarelin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Shanghai Soho-Yiming Pharmaceuticals
CPC Scientific
Hangzhou Longshine Bio-Tech

Nafarelin market size by Type
Nasal Spray
Freeze-dried Powder
Nafarelin market size by Applications
Central Precocious Puberty

Market size by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:
To study and analyze the global Nafarelin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Nafarelin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nafarelin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Nafarelin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Nafarelin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (g). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nafarelin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Nafarelin Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Nafarelin Market Size Growth Rate by Type
1.4.2 Nasal Spray
1.4.3 Freeze-dried Powder
1.5 Market by Application
1.5.1 Global Nafarelin Market Size Growth Rate by Application
1.5.2 Central Precocious Puberty
1.5.3 Endometriosis
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Nafarelin Market Size
2.1.1 Global Nafarelin Revenue 2014-2025
2.1.2 Global Nafarelin Sales 2014-2025
2.2 Nafarelin Growth Rate by Regions
2.2.1 Global Nafarelin Sales by Regions
2.2.2 Global Nafarelin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Nafarelin Sales by Manufacturers
3.1.1 Nafarelin Sales by Manufacturers
3.1.2 Nafarelin Sales Market Share by Manufacturers
3.2 Nafarelin Revenue by Manufacturers
3.2.1 Nafarelin Revenue by Manufacturers (2014-2019)
3.2.2 Nafarelin Revenue Share by Manufacturers (2014-2019)
3.3 Nafarelin Price by Manufacturers
3.4 Nafarelin Manufacturing Base Distribution, Product Types
3.4.1 Nafarelin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nafarelin Product Type
3.4.3 Date of International Manufacturers Enter into Nafarelin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Nafarelin Sales by Type
4.2 Global Nafarelin Revenue by Type
4.3 Nafarelin Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Nafarelin Breakdown Data by Application

6 North America
6.1 North America Nafarelin by Country
6.1.1 North America Nafarelin Sales by Country
6.1.2 North America Nafarelin Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Nafarelin by Type
6.3 North America Nafarelin by Application

7 Europe
7.1 Europe Nafarelin by Country
7.1.1 Europe Nafarelin Sales by Country
7.1.2 Europe Nafarelin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nafarelin by Type
7.3 Europe Nafarelin by Application

8 Asia Pacific
8.1 Asia Pacific Nafarelin by Country
8.1.1 Asia Pacific Nafarelin Sales by Country
8.1.2 Asia Pacific Nafarelin Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Nafarelin by Type
8.3 Asia Pacific Nafarelin by Application

9 Central & South America
9.1 Central & South America Nafarelin by Country
9.1.1 Central & South America Nafarelin Sales by Country
9.1.2 Central & South America Nafarelin Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Nafarelin by Type
9.3 Central & South America Nafarelin by Application

10 Middle East and Africa
10.1 Middle East and Africa Nafarelin by Country
10.1.1 Middle East and Africa Nafarelin Sales by Country
10.1.2 Middle East and Africa Nafarelin Revenue by Country
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Nafarelin by Type
10.3 Middle East and Africa Nafarelin by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Nafarelin Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Nafarelin Products Offered
11.1.5 Pfizer Recent Development
11.2 Shanghai Soho-Yiming Pharmaceuticals
11.2.1 Shanghai Soho-Yiming Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Shanghai Soho-Yiming Pharmaceuticals Nafarelin Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Shanghai Soho-Yiming Pharmaceuticals Nafarelin Products Offered
11.2.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
11.3 CPC Scientific
11.3.1 CPC Scientific Company Details
11.3.2 Company Business Overview
11.3.3 CPC Scientific Nafarelin Sales, Revenue and Gross Margin (2014-2019)
11.3.4 CPC Scientific Nafarelin Products Offered
11.3.5 CPC Scientific Recent Development
11.4 Hangzhou Longshine Bio-Tech
11.4.1 Hangzhou Longshine Bio-Tech Company Details
11.4.2 Company Business Overview
11.4.3 Hangzhou Longshine Bio-Tech Nafarelin Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Hangzhou Longshine Bio-Tech Nafarelin Products Offered
11.4.5 Hangzhou Longshine Bio-Tech Recent Development

12 Future Forecast
12.1 Nafarelin Market Forecast by Regions
12.1.1 Global Nafarelin Sales Forecast by Regions 2019-2025
12.1.2 Global Nafarelin Revenue Forecast by Regions 2019-2025
12.2 Nafarelin Market Forecast by Type
12.2.1 Global Nafarelin Sales Forecast by Type 2019-2025
12.2.2 Global Nafarelin Revenue Forecast by Type 2019-2025
12.3 Nafarelin Market Forecast by Application
12.4 North America Nafarelin Forecast
12.5 Europe Nafarelin Forecast
12.6 Asia Pacific Nafarelin Forecast
12.7 Central & South America Nafarelin Forecast
12.8 Middle East and Africa Nafarelin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nafarelin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer